跳至主要内容
临床试验/CTRI/2013/07/003805
CTRI/2013/07/003805招募中4 期

A comparative study of efficacy and tolerability of alfuzosin, tamsulosin and silodosin in benign prostatic hyperplasia.

Dr Manjunatha R0 个研究点目标入组 90 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Male subjects more than or equal to 45 years with BPH and associated LUTS;
  • IPSS more than or equal to 8.
  • QLS more than or equal to 3.
  • Qmax less than 15ml but more than 4ml with a voided volume of more than 100ml.
  • willingness to give written informed consent and comply with the study procedure, and available for regular follow up.

排除标准

  • Patients already on 5 alpha reductase inhibitors.
  • Severe hepatic or renal insufficiency.
  • Patients concomitantly receiving strong CYP3A4 inhibitors.
  • Urethral stricture.
  • Neurogenic bladder.
  • PSA more than or equal to 5ng/ml.
  • History of urethral or prostatic operation.
  • Likely to need catheterization within next 3 months.
  • Hypotension or severe untreated hypertension.
  • History of esophageal or intestinal obstruction.
  • Patients receiving drugs that may interfere with the response to study medications within previous 6 months like verapamil, androgens, anti-androgens, diuretics, cholinergics, anti-cholinergics and phytotherapy.
  • History of alcohol or drug abuse.
  • Currently suffering from serious disease or malignancy.
  • Significant psychiatric problems.
  • Patients at increased risk of QTc prolongation.

研究者

发起方
Dr Manjunatha R

相似试验

已完成
不适用
A study to compare two drugs benzoyl peroxide and azelaic acid for improvement in symptoms and skin tolerability
CTRI/2022/03/041085Raghav M V120
已完成
不适用
Efficacy and tolerability of iron polymaltose and ferrous gluconate with lactoferrin as a combination in treatment of iron deficiency anemiaIron deficiency anemia
PACTR201806003419426Pediatric departement faculyty of medicine, Alexandria University100
进行中(未招募)
不适用
Comparative study of the efficacy and tolerability of iron polymaltose complex film-coated tablets with folic acid (Maltofer® Fol film-coated tablets) compared to a generic iron sulphate product in pregnant women with iron-deficiency anaemiaIron deficiency among pregnant women.MedDRA version: 9.1Level: LLTClassification code 10022972Term: Iron deficiency anaemia
EUCTR2007-001517-41-BGVifor (International) Inc.423
进行中(未招募)
不适用
Comparative study of the efficacy and tolerability of iron polymaltose complex film-coated tablets with folic acid (Maltofer® Fol film-coated tablets) compared to a generic iron sulphate product in pregnant women with iron-deficiency anaemiaIron deficiency among pregnant women.MedDRA version: 9.1Level: LLTClassification code 10022972Term: Iron deficiency anaemia
EUCTR2007-001517-41-LVVifor (International) Inc.348
进行中(未招募)
不适用
Comparative study of the efficacy and tolerability of iron polymaltose complex film-coated tablets with folic acid (Maltofer® Fol film-coated tablets) compared to a generic iron sulphate product in pregnant women with iron-deficiency anaemiaIron deficiency among pregnant women.MedDRA version: 9.1Level: LLTClassification code 10022972Term: Iron deficiency anaemia
EUCTR2007-001517-41-EEVifor (International) Inc.423